-
-
Toggle navigation
Impact Factor 3.113 | CiteScore 3.03
More on impact ›
in Medicine |
|
Submit your manuscript
Scope
The section Nuclear Medicine aims to publish studies from the entire field, including the routine use of nuclear medicine tools for imaging and therapy, clinical trials, experimental molecular imaging and radionuclide therapy, radiobiology, radiopharmaceuticals, quantitative imaging and dosimetry.
Scope
The specialty section Nuclear Medicine is dedicated to the publication of results from preclinical research, translational research and clinical studies applied to nuclear medicine. Nuclear Medicine aims to publish studies from the entire field of nuclear medicine: results from the routine use of nuclear medicine tools for imaging and therapy, from clinical trials, experimental molecular imaging and radionuclide therapy in humans and animals, research on radiobiology, radiopharmaceuticals, quantitative imaging and dosimetry. The section Nuclear Medicine has a particular interest in:
- Clinical studies that assess new nuclear medicine methods or new radiopharmaceuticals in order to improve the management of patients at the era of personalized medicine
- Research studies that aim to establish the role of new or existing radiopharmaceuticals for the molecular characterization of disease before and after treatment, with the ultimate goal of personalized patient treatment
- Research studies that aim to assess new radiopharmaceuticals or new procedures for radionuclide therapy
- Research studies that aim to develop and assess new techniques for imaging analysis and quantification and for dosimetry
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, Emerging Sources Citation Index, CLOCKSS
PMCID: all published articles receive a PMCID
Nuclear Medicine welcomes submissions of the following article types: Brief Research Report, Case Report, Clinical Trial, Community Case Study, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Original Research, Perspective, Review, Study Protocol and Systematic Review.
All manuscripts must be submitted directly to the section Nuclear Medicine, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Nuclear Medicine will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Medicine.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact medicine.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact medicine@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org